Clear Street’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Clear Street’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$222K	Hold	21,000	–	–	﹤0.01%	539
2025 Q4	$222K	Sell	21,000 -1,000	-5%	-$10.6K	﹤0.01%	443
2025 Q3	$231K	Hold	22,000	–	–	﹤0.01%	341
2025 Q2	$230K	Buy	22,000 +15,975	+265%	+$166K	﹤0.01%	207
2025 Q1	$61.6K	Sell	6,025 -10,047	-63%	-$101K	﹤0.01%	170
2024 Q4	$160K	Buy	+16,072	New	+$160K	﹤0.01%	105

Other funds holding OACC

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Clear Street's OACC Position: Q1 2026 in Review

Clear Street held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 21,000 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Clear Street first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. The position peaked at $231K in Q3 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

Clear Street held 21,000 shares of Oaktree Acquisition Corp III Life Sciences worth $222K as of Q1 2026.
Clear Street left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #539 holding.
Clear Street first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
Clear Street's Oaktree Acquisition Corp III Life Sciences position peaked at $231K in Q3 2025.
51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.